Human hepatocellular carcinoma (HCC) is the most frequent primary tumor of the liver and it is the third cause of cancer-related deaths. The prognosis of HCC is poor and thus the identification of novel molecular biomarkers for the early diagnosis in at-high risk patients is needed. Circulating ncRNAs (including lncRNAs and miRNAs) have been detected in different human body fluids. In order to identify promising circulating diagnostic molecular biomarkers, we measured the levels of selected ncRNAs in plasma from HCC patients.

Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC

Ilaria Grossi;Michele Manganelli;Teresa Faranda;Massimo Negrini;Gianluca Baiocchi;Nazario Portolani;Giuseppina De Petro;Alessandro Salvi
2019-01-01

Abstract

Human hepatocellular carcinoma (HCC) is the most frequent primary tumor of the liver and it is the third cause of cancer-related deaths. The prognosis of HCC is poor and thus the identification of novel molecular biomarkers for the early diagnosis in at-high risk patients is needed. Circulating ncRNAs (including lncRNAs and miRNAs) have been detected in different human body fluids. In order to identify promising circulating diagnostic molecular biomarkers, we measured the levels of selected ncRNAs in plasma from HCC patients.
File in questo prodotto:
File Dimensione Formato  
2019 Grossi I et al EACR-ESMO congress abstract.pdf

accesso aperto

Tipologia: Abstract
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 142.29 kB
Formato Adobe PDF
142.29 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11379/515989
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact